ASSESSMENT OF INNOVATIVE ACTIVITY OF KAZAKHSTAN HEALTHCARE ORGANIZATIONS
indicator Kazakhstan ranked 96th out of 144 countries. According to the Human Development Index, Kazakhstan joined the group of countries with high development level, finishing in 70th place out of 187 countries [15; 18] .
Being originated as order of patient to doctor, medical aid over time has gained the legal status of services. Medical services are considered as activities of healthcare subjects, with preventive, diagnostic, therapeutic or rehabilitative orientation towards a specific person.
The market of medical services as a developed system of relations of commodity and noncommodity exchange is the part of healthcare market, which directly affects the nation's health and quality of life of the population and requires state regulation of the market processes.
Development of healthcare and medical services market related to targeted improvement in quality, comprehensiveness, availability of services and introduction of innovative medical technology.
The main types of innovation in health are the following:  pharmaceutical innovation is the development of new drugs;  technological innovation associated with the emergence of new methods of prevention and treatment of diseases on the basis of existing drugs or new combinations of their application;
 organizational innovations involve improving the organization of labor and efficiency management;  economic innovation is the introduction of new methods of planning and financing of medical institutions activities;
 information-technological innovations aimed at automation of information flows in the industry. Analyzing innovative activities in healthcare, all innovations in this industry can be divided into the following four groups ( In full innovation in healthcare includes all types of research (fundamental, search, applied), development of innovations and introduction of a medical organization, i.e. the implementation of innovations.
Thanks to innovations in medicine, healthcare has reached a higher level, the duration and quality of human life is increasing, the dynamics of rendering high-tech medical care not only abroad, but also in the CIS countries, including in Kazakhstan, is growing.
Kazakhstan has accumulated a wealth of experience in reforming the economy: many difficulties had to be overcome, mistakes were corrected, shortcomings were eliminated, and some initial guidelines were revised. Some positive results of economic reforms have also been obtained: high rates of production growth were been achieved, and the living standard of the population has risen. Along with this, the influence of braking factors remains: the sectoral structure of the economy needs improvement, and the level of economic efficiency of production can not be considered satisfactory.
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Leading role in the reform belongs to institutional reforms, including the real maintenance of property rights, effective antitrust legislation and control over its implementation, strict banking supervision, insurance of bank deposits, etc. In their absence, a "system vacuum" arises, directly leading to the criminalization of economic life, the growth of the clan and shadow economy, the growth of non-payments.
Steady high dynamics of economic growth and favorable conjuncture in the world market allowed Kazakhstan to set and solve certain tasks until 2015 to give the domestic economy an innovative and socially-oriented character [19] .
Nevertheless, Kazakhstan is at the tail of the list of countries that are effectively engaged in the development of innovations in medicine. Historically, the USA, Germany, Great Britain and Japan are leaders in this market. Recently, India and China are actively expressing themselves. The share of domestic innovative drugs, even on the domestic market, is very small (a few percent). About 70% of the resources required for the production of finished medicines are supplied from India, China and other countries, and the volume of exports of finished medicines and pharmaceutical substances from Kazakhstan is less than 0,1% of global sales. The main reason for this is a sharp reduction in the funding of research in 1990-2007 and a shortage of qualified personnel.
Since there is a large amount of state intervention in Kazakhstan, the responsibility for implementing innovative health projects is directly assigned to medical organizations and the authorized body There is the growth in domestic expenditure on research and development, which reached 208,52 million euro (about 231 million USD) with growth of 18,2 % compared to 2014, while their share to GDP increased to 0,17 % (Figure 3) . Every year, the current expenditure on technological innovation of healthcare enterprises is growing, in recent years, the volume of innovative products has significantly increased.
According to the recommendations of the World Health Organization the cost of medicine needs to be at least 5% of GDP for the effective performance of its functions. Alongside with it there remains the influence of factors of inhibition: non-diversified sectorial structure of the economy remains on the low level of economic efficiency of production. Kazakhstan is situated at the end of the list of countries effectively engaged in the development of medical innovations.
The analytical group of the World Economic Forum, all countries participating in the ranking, are divided into three groups depending on the stage of development of the country, determined by the level of GDP per capita and the degree of conditionality of the country by the basic factors. The first category is countries, the economy, which is driven by "production factors". This group includes 38 countries (Kyrgyzstan, Moldova, India, Bangladesh, etc.). The second group is the countries, the economy, which is driven by "management effectiveness" (Armenia, Ukraine, China, etc.). The third group is the countries, the economy, which is driven by innovations (35 countries: Australia, Austria, Finland, Japan, South Korea, USA, Norway, France etc.) [21] .
According to the results of the rating in 2014, Kazakhstan, moved through one stage to the next intermediate group (2) (3) , located between the categories of countries driven by "management effectiveness" and "innovation". This group also includes countries such as Argentina, Brazil, Hungary, Malaysia, Latvia, Poland, the Russian Federation, Turkey and others. In 2015, Kazakhstan retained this provision.
The rating is headed by such countries as Switzerland, Singapore, Finland. Thus, Kazakhstan retains the second result among the CIS countries after Azerbaijan (39th place). Russia occupies the 64th place, Ukraine -84th, the Kyrgyz Republic -121st place [24] . The global competitiveness index of WEF is formed from a combination of three sub-indexes: "Factors of basic conditions", "Efficiency factors", "Factors of innovation", which are subdivided into factors and sub-factors. According to this system of assessments in Kazakhstan there is an improvement in the factors of "Quality of institutions", "Higher education and professional training", "Factors of innovation", "Competitiveness of companies". However, there was a decline in the rating by the "Health and primary education" factor from 85 to 92.
For the "Innovation potential" factor, the growth of Kazakhstan's position increased by 13 points (in 2013 -116, in 2014 -103). There is a growth in the "Quality of scientific research institutions" sub-factor. According to this indicator in 2013 Kazakhstan the 121, in 2014 -108 13 points raised Kazakhstan's rating for "Expenses of companies on research and development" sub-factor (2013 -107, in 2014 -94). There were improved linkages between Universities and industry in the field of research and development, in 2014, an increase of 29 points, in 2013 -119, in 2014 -90. There was observed a positive shift of Kazakhstan in 2014 on the "Public procurement of high-tech products" sub-factor from 93 to 71 [39] .
In the framework of technology commercialization system development of the National Agency for technical development (further -NATD) established 15 commercialization offices and 4 regional commercialization centers, ready to provide support and expert assistance to scientists and innovators in the process of innovations commercialization.
Under the terms of financing investment of NATD in one innovative project should not exceed 49% of the project cost, with the term of participation in the project to 5 years. In 2014-2015 for the provision of innovative grants there were allocated 8,8 billion tenge from the Republican budget, due to which in 2014 there were funded 37 projects worth 1,7 billion tenge, in 2015 -129 projects amounting to 7,1 billion tenge, in the reporting period work was carried out for their implementation and monitoring.
According to the NATD innovative activity in organizations of the health system remains on the low level. Quality of submitted applications does not meet the General requirements of NATD, in connection with it projects do not receive a positive decision of the Commission.
Results of an online survey of medical specialists on the innovative activities in the Republic of Kazakhstan have identified the reasons inhibiting the activity of development and implementation of innovations.
In the second half of 2015, we conducted a survey that allowed us to draw certain conclusions about the level of innovative activity in the healthcare of Kazakhstan.The sample of respondents reached 849 human which was attended by specialists of all levels. However, it should be noted that respondents of district medicine made only 15,5%. The number of respondents was dominated by the leaders of various levels (about 47%), reflecting their leading role in facilitating innovation in medical institutions.
In general, among the respondents in the occupied positions, the experts occupying leading positions is 46,7%, the heads of the department is 20,6%, the deputies of the first head is 15,3%, the first leaders of the organization is 7,9%, the heads of departments -3,9%, heads of department / department -3,5% and less participated in the survey of heads of sectors -2,0% of cases. That is, health professionals in Kazakhstan, actively involved in innovation, are mainly represented by representatives from the capital's regions and cities of the republic, the administrative and management apparatus, in the age category over 40 years.
As shown by the analysis of the questionnaire, the main share of innovations being developed in healthcare organizations falls on practical medicine -38,6%, education -9,1%, organizational and managerial technologies -8,7% and scientific research -5,3%. The analysis showed that medicine innovations in Kazakhstan are implemented primarily in the practice of medicine (39%), although they are born in a research (40%). According to the authors, insufficient level of innovation attributable to education (less than 10%) risks of resistance to the innovative development of future professionals and to creation of an institutional threat to the backlog of Kazakh medicine. According to the study every tenth medical facility do not introduce innovative technologies, more than half of clinical staff are not involved in the implementation of research programs. Every fifth healthcare professional is not involved in innovative activities. Unfortunately, the low level of involvement of experts in preclinical studies, where medical innovations are usually originated. The results of the questionnaire showed that only 26,4% of specialists participated in the development of methodological recommendations for practical health care, 24,6% of respondents received acts of introducing innovations from different regions of the Republic, 17,7% had patents of the RK, 17% participated in the development of clinical Protocols and only 11,4% had author's certificates of innovation (r = 0.830).
Most Kazakhstani doctors and nurses who participated in the survey (62,4%) say that we are introducing the borrowed innovations. Introduction to advanced medical technology is a positive process, especially if it encourages professionals to own innovation. According to the estimates of respondents there are already 27% of the organizations introducing innovations and inventions that are created directly in a medical facility. The authors note the insufficient level of competence of doctors and nurses for the work with information. Mostly professionals search for information on the Internet (23%), but not widely discuss it in the professional community at work (17%). Only 16% of respondents use scientific publications for new information, while professional culture assumes that 100% of health workers should regularly read core publications. The authors also note the lack of ability to handle empirical data and, in particular, to use databases of evidence-based medicine and clinical protocols (14% and 15%, respectively). That is evidence-based medicine that is currently a source of competitive innovation, the ability to use modern research methods it is a mandatory part of professional competence in medicine. Respondents (23%) noted the lack of expertise and lack of awareness about the achievements of medical science and practice. High efficiency of joint learning within the organization (31%) confirms the high potential of selflearning forms, which is one of the signs of a professional community.
Another advantage of the network community is a free exchange of information sent and repeatedly checked in the network. The authors believe that overcoming the shortcomings of innovative activity of the Kazakhstan doctors is consisted from stimulation of professional networking communities. Professional medical communities are determined by the type of knower networks, joining self-education factors. More than half (59%) of respondents noted difficulties of the staff to have access to resources of scientific and technical information of the organization, while at the network there is freely circulating the professional information at various levels.
Belonging to a professional network community also solves the task to stimulate participants to produce the innovative product. In the medical environment, there are many complaints of excessive workload (13%), weak physical infrastructure and inefficiency of the bodies responsible for the development and implementation of the innovation (12%). Half of the respondents noted the lack of material interest. World experience shows that the professional network of doctors is an effective tool for the creation, accumulation and exchange of information among members of the network. Medical organizations use the medical community as the impact on consumers, as well as a resource for professional growth and career advancement of doctors.
Comparative analysis of factors of influence on staff's involvement in innovative activity shows the presence of significant creative potential in the Kazakh medicine. Training at the workplace allowing partial compensation for the workload of doctors. The high level of demand for internships creates an additional incentive for specialists-innovators. Access to information becoming available in recent years is allowing compensation for the still significant lack of knowledge [30; 31] . Based on the analysis of the results of the research of innovative activity in the healthcare of Kazakhstan, we conducted a SWOT-analysis (Table 1) : Weaknesses -political support of the state at the highest level and guaranteeing the fulfillment of the social obligations taken; -stable epidemiological situation for the majority of infectious diseases with high immunization coverage; -good provision of stationary organizations; -experience of transfer of modern medical technologies and highly specialized medical care; -development of transport medicine; -introduction of the accreditation system; -creating priorities for the development of domestic manufacturers of medicines; -more precise orientation of services for consumers -low life expectancy, high level of overall mortality in comparison with the average level of European countries; -low level of the share of GDP for financing healthcare; -high level of private healthcare expenditure; -insufficient level of financing of primary healthcare; -the lack of mechanisms for joint responsibility for health; -insufficient participation of the private sector in providing a guaranteed volume of free medical care; -low level of corporate governance; -low labor motivation and professionalism of medical personnel; -insufficient medicines at the outpatient level; -insufficient shared responsibility of the population for their health; -the complexity of forecasting for a long period due to changes in the market conditions and volatility of the national currency exchange rate Opportunities Threats -introduction of social health insurance based on implemented market mechanisms (a single payer was established, modern methods of payment were introduced, taking into account the developed protocols and standards); -investment support of the World Bank and other international financial institutions; -development of the medical tourism market; -increasing competitiveness in the health care market and possible direct investment in health care; -transfer of knowledge and best practices through intensive communication and cooperation with European experts -further worsening of the global economic situation; -increased demand for medical services; -the growing costs of health care not covered by budgetary funds alone; -growth of non-communicable diseases; -the presence of natural foci of especially dangerous infections on the territory of the country and the weakening of the role of the sanitary and epidemiological service; -counterfeit medicinal products In the opinion shared by the medical community, the main reason for the low innovation activity is the level of knowledge of professionals on the latest achievements of science, lack of trained personnel and lack of target financing of innovation in healthcare.
Conclusion and directions for further research. Kazakhstan medicine largely lags behind both of the world's level of development and demands of modern society. The main reason for this is the drastic reduction of research funding in 1990-2007 and the shortage of qualified personnel.
Low innovation activity of health care organizations not only reduces the quality of life of the population, but also poses a severe risk to increase in the future. Scientific organizations of the healthcare system must recognize the critical role of innovation in successful organization of its activities, conquest of new markets, strengthening competitive advantages.
Results of the analysis also indicate the need to intensify inter-sectorial cooperation and involvement of business structures in the sphere of development and introduction of new medical technologies in practical public health. Expert analysis conducted during the study has identified promising opportunities and directions of development of innovative activities in healthcare. As breakthrough technologies there were marked innovative forms of organization of medical-diagnostic process, new approaches to staffing, efficient management of organizational projects. As priority directions of development there was defined the development of innovative infrastructure and innovative forms of the organization of the activities of the institution. Opportunity to upgrade innovation activities in healthcare is the integration of science and business, with the goal of commercialization of medical products by creating a public-private partnership or the transition of health care institutions in the new economic mechanism, with the involvement of extra-budgetary allocations.
To overcome barriers in the process of innovation in health care, it is necessary:  to create a cohesive multidisciplinary team, the following principles of independence, evidence and transparency;
 ensure effective public-private partnerships in the implementation of innovative projects;  to stimulate the attraction of foreign investment in high technology high-tech healthcare;  identify priority areas of scientific and technical activities for the implementation of competitive applications;
 create channels of external and internal information;  strengthen interaction with other research institutions and research-and-production enterprises. 
